Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Evaluation of sequence of therapy on anti-tumor activity in the SORAYA study (002)

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2023-09, Vol.176, p.S3-S3
Main Authors: Coleman, Robert, Oaknin, Ana, Pignata, Sandro, Denys, Hannelore, Colombo, Nicoletta, Van Gorp, Toon, Konner, Jason, Marin, Margarita Romeo, Harter, Philipp, Murphy, Conleth, Esteves, Brooke, Method, Michael, Lorusso, Domenica, Matulonis, Ursula
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2023.06.468